SCHEMBL7900190

SCHEMBL7900190

CC(C)(C)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccc(O)c(C(C)(C)C)c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.41
ACE P12821 5/20 0.40
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
CA2 P00918 2/20 0.38
NAALAD2 Q9Y3Q0 1/20 0.36
MME P08473 5/20 0.36
CPA1 P15085 3/20 0.36
ACE2 Q9BYF1 3/20 0.36
PTPN1 P18031 1/20 0.36
CTSS P25774 2/20 0.36
CTSK P43235 2/20 0.36
CTSB P07858 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7898816 0.87 HDAC3 (0.41) FOLH1ACEITGB3ITGA2BCA2
SCHEMBL7900674 0.85 ACE (0.46) ACEITGB3ITGA2BMMECTSS
SCHEMBL9287295 0.83 ACE (0.38) FOLH1ACEITGB3ITGA2BCA2
SCHEMBL8215159 0.81 FOLH1 (0.43) FOLH1ACECA2MMEACE2
SCHEMBL10657027 0.80 ACE (0.57) ACEITGB3ITGA2BPTPN1CTSS
SCHEMBL10657017 0.80 ACE (0.57) ACEITGB3ITGA2BPTPN1CTSS
SCHEMBL7261799 0.80 MMP1 (0.38) CTSSCTSKCTSBHDAC3HDAC4
SCHEMBL7257429 0.79 CTSL (0.43) ACEPTPN1CTSSCTSKCTSB
SCHEMBL8214039 0.77 ACE (0.41) ACEMMECPA1ACE2CTSS
SCHEMBL9101075 0.76 FOLH1 (0.51) FOLH1ACECA2NAALAD2MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6319702-B1 NUCLEOTIDE SEQUENCS CODING AN ENZYMATIC POLYPEPTIDE AND CELL TARGETING COMPOUND; FOR USE IN TREATMENT OF CANCER GLAXO WELLCOME, INC. 2001-11-20 US disclosed